Notably, CSNK2A1 transcripts and proteins are reported to be upregulated in many kinds of cancers 4,22, such as multiple myeloma 23, breast cancer 11, and liver cancer 12. This evidence concerns the gene CSNK2A1 and AL amyloidosis.